CTRI/2022/12/048517尚未招募未知
Safety and efficacy of vigabatrin add on compared to placebo in Lennox-Gastaut Syndrome: A randomizedcontrolled trial
Dr Jayantee Kalita Principal Investigator0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children aged 2 to 18 years having LGS who are using 2-5 antiepileptic drugs (AED) for 1month will be eligible for enrolment.
排除标准
- •Progressive cognitive or neurological deficit, known degenerative neurological disease or metabolic disease,hemi-clonic seizures in the first year of life, only clusters of drop seizure, visual loss, hepatic disease, and if concomitant ketogenic diet, cannabidiol, fenfluramine use at the time of enrolment.
研究者
相似试验
招募中
2 期
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in InfantsTuberous Sclerosis ComplexNCT04987463Katarzyna Kotulska60
招募中
不适用
Comparison of efficacy and safety of Vildagliptin and Teneligliptin in patients with Type 2 Diabetes MellitusCTRI/2017/02/007766jawaharlal nehru medical college and hospital160
已完成
Unknown
Vigabatrin film coated tablet BioequivalenceBioequivalence study in healthy volunteers.IRCT20130313012810N32Modava Pharmaceutical Company24
未知
3 期
To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesType 2 DiabetesJPRN-jRCT2080220294ovartis Pharma K.K.370
招募中
Unknown
Study of additional vibegron in persistent overactive bladderoveractive bladderJPRN-jRCTs031230450Yoshida Masaki160